In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...
The models are designed to predict someone’s risk of diabetes or stroke. A few might already have been used on patients.
ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the ...
In the current global oncology landscape, solid tumors comprise over 70% of all cancer cases. They are responsible for the majority of cancer-related ...
A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results